SVF Endurance (Cayman) Ltd, 10% Owner at Vir Biotechnology, Inc. (VIR), sold 59,030 shares at $6.07 ($359K) on 2025-10-15, disclosed to the SEC on 2025-10-17.
Scheduled sale ($359k) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.07 | 16,671 | $101K | 28.2% |
| 2 | $6.07 | 16,671 | $101K | 28.2% |
| 3 | $6.10 | 12,844 | $78K | 21.8% |
| 4 | $6.10 | 12,844 | $78K | 21.8% |
| Total | $6.08 avg | 59,030 | $359K | 100% |
| Filing → |
| VIR | SELL | 2025-10-30 | $319K | — | Filing → |
| VIR | SELL | 2025-10-22 | $2.7M | — | Filing → |
| VIR | SELL | 2025-10-07 | $5.8M | — | Filing → |